comparemela.com

Page 16 - Cardiff Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Head-To-Head Contrast: Cardiff Oncology (NASDAQ:CRDF) & Dyadic International (NASDAQ:DYAI)

Dyadic International (NASDAQ:DYAI – Get Rating) and Cardiff Oncology (NASDAQ:CRDF – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares Dyadic International and […]

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 20, 2023 /PRNewswire/ Cardiff Oncology, Inc. , a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies. | June 20, 2023

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug.

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cardiff Oncology to Present at the Jefferies Healthcare Conference

Cardiff Oncology to Present at the Jefferies Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.